Anti-pseudomonal cephalosporin

This page covers all Anti-pseudomonal cephalosporin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Penicillin-binding proteins (PBPs).

Targets

Penicillin-binding proteins (PBPs)

Marketed (1)

• anti-pseudomonal cephalosporin · Vanderbilt University Medical Center · Infectious Disease
  Anti-pseudomonal cephalosporins inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell wall disruption and bacterial death.

Patent intelligence

• pseudomonal cephalosporin patent landscape — aggregated cliff calendar, attackable patents, originator estates